⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FTRE News
Fortrea Holdings Inc. Common Stock
Caidya ernennt Michael Clay zum COO, um die operative Exzellenz zu fördern und die multiregionale klinische Entwicklung voranzutreiben
businesswire.com
FTRE
Caidya ernennt Michael Clay zum COO, um die operative Exzellenz zu fördern und die multiregionale klinische Entwicklung voranzutreiben
businesswire.com
FTRE
Caidya nomme Michael Clay COO pour renforcer l'excellence opérationnelle et faire progresser le développement clinique multirégional
businesswire.com
FTRE
Caidya nomme Michael Clay COO pour renforcer l'excellence opérationnelle et faire progresser le développement clinique multirégional
businesswire.com
FTRE
Fortrea Holdings, Inc. (FTRE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
FTRE
Caidya Names Michael Clay COO to Drive Operational Excellence and Advance Multi-Regional Clinical Development
businesswire.com
FTRE
Caidya Names Michael Clay COO to Drive Operational Excellence and Advance Multi-Regional Clinical Development
businesswire.com
FTRE
Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services
globenewswire.com
FTRE
Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings, Inc. (FTRE) And Encourages Investors to Connect
accessnewswire.com
FTRE
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings, Inc. (FTRE) and Encourages Stockholders to Learn More About the Investigation
accessnewswire.com
FTRE